COSCIENS Biopharma Inc
TSX:CSCI

Watchlist Manager
COSCIENS Biopharma Inc Logo
COSCIENS Biopharma Inc
TSX:CSCI
Watchlist
Price: 5.8 CAD 7.01% Market Closed
Market Cap: 18.3m CAD

Relative Value

The Relative Value of one CSCI stock under the Base Case scenario is hidden CAD. Compared to the current market price of 5.8 CAD, COSCIENS Biopharma Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CSCI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
79
Median 3Y
3.9
Median 5Y
11.4
Industry
7.6
vs History
vs Industry
Median 3Y
-2
Median 5Y
-3.3
Industry
24.2
vs History
vs Industry
Median 3Y
-3
Median 5Y
-4.6
Industry
20.3
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-4.5
Industry
22.9
vs History
69
vs Industry
69
Median 3Y
1.2
Median 5Y
1.8
Industry
2.9
vs History
vs Industry
Median 3Y
-0
Median 5Y
3.2
Industry
7.9
vs History
vs Industry
Median 3Y
-0
Median 5Y
3.3
Industry
10
vs History
28
vs Industry
24
Median 3Y
0
Median 5Y
-1.5
Industry
5.1
vs History
28
vs Industry
22
Median 3Y
0
Median 5Y
-1.5
Industry
5.1
vs History
28
vs Industry
27
Median 3Y
0
Median 5Y
-1.7
Industry
5.7
vs History
28
vs Industry
23
Median 3Y
0
Median 5Y
-1.7
Industry
4.2
vs History
vs Industry
Median 3Y
1.8
Median 5Y
5.4
Industry
5.2

Multiples Across Competitors

CSCI Competitors Multiples
COSCIENS Biopharma Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
COSCIENS Biopharma Inc
TSX:CSCI
18.2m CAD 1.5 -0.8 -0.1 -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 159 077.2 -162 353 -197 148.4 -194 898.7
US
Abbvie Inc
NYSE:ABBV
334.3B USD 5.8 80.5 15.3 22.6
US
Amgen Inc
NASDAQ:AMGN
158.5B USD 4.6 26.7 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
134.7B USD 4.7 22.6 9.8 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.2B USD 10.6 -119.5 25.4 26.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 062.4 -526.3 -573.1 -557.8
AU
CSL Ltd
ASX:CSL
124.6B AUD 5.3 29.5 18.1 22.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
58.7B USD 4.2 13 11.6 13.1
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -60.9 -65.7 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.8B USD 17.8 -154.9 -694.7 -348.1
P/S Multiple
Revenue Growth P/S to Growth
CA
COSCIENS Biopharma Inc
TSX:CSCI
Average P/S: 3 105 564.9
1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 159 077.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.7
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.6
10%
1.1
US
E
Epizyme Inc
F:EPE
2 062.4
N/A N/A
AU
CSL Ltd
ASX:CSL
5.3
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.2
4%
1
US
S
Seagen Inc
F:SGT
19.9
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.8
30%
0.6
P/E Multiple
Earnings Growth PEG
CA
COSCIENS Biopharma Inc
TSX:CSCI
Average P/E: 34.5
Negative Multiple: -0.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 353 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.5
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.7
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.6
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -119.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.3 N/A N/A
AU
CSL Ltd
ASX:CSL
29.5
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -154.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
COSCIENS Biopharma Inc
TSX:CSCI
Average EV/EBITDA: 15.8
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 148.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.3
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.4
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -573.1 N/A N/A
AU
CSL Ltd
ASX:CSL
18.1
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.6
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -694.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
COSCIENS Biopharma Inc
TSX:CSCI
Average EV/EBIT: 20.4
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 898.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.6
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.8 N/A N/A
AU
CSL Ltd
ASX:CSL
22.7
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.1
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -348.1 N/A N/A